Hepatology Associates Course, Part 2: Novel Insights From Hepatology Associates
Nov
09
2025
Convention Center: Room 146B, Level 1
11:00 AM - 12:30 PM
Description
The Associates Course expands the knowledge base of participants to improve patient outcomes in behavioral, nutritional, and pharmacologic interventions in chronic liver disease. Speakers explore topics including: (1) novel treatment models of chronic hepatitis C and MASLD/MASH; (2) pharmacist driven management of chronic liver disease; (3) resource-limited management of chronic liver disease; and (4) palliative approaches to management of patients with chronic liver disease.Journey Maps
Presentations
11:00 AM - 11:20 AM
Nov
09
2025
Washington, D.C.
The Ongoing Emergence of the Clinical Pharmacist in Hepatology
Lindsey P Sheehan, PharmD, MPA, MBA, Presenter
Hepatology Associates
11:20 AM - 11:40 AM
Nov
09
2025
Washington, D.C.
Taking It to the Streets: Field Medicine as a Means to Eliminate Hepatitis C
Kevin R Leyden, RN, Presenter
Hepatology Associates
11:40 AM - 12:00 PM
Nov
09
2025
Washington, D.C.
Pharmacology Update: First Year With Resmetirom and Peroxisome Proliferator-Activated Receptor Agonists
Allison Moser, MSN, Presenter
Hepatology Associates
12:00 PM - 12:20 PM
Nov
09
2025
Washington, D.C.
Bridging Primary Care and Hepatology in Resource-Limited Settings
Jimyeong Son, AGPCNP-BC, Presenter
Hepatology Associates
Objectives
- Explore novel field-based models of hepatitis C management and discuss the expanded scope of clinical pharmacists in hepatology care.
- Review strategies for optimization of hepatology care in nonspecialist and resource-limited settings.
- Summarize clinical use of recently approved medications indicated for MASH and primary biliary cholangitis.
Chair
Scott Springer, PA-C, MPAS
Erie County Medical Center
Chair
Elizabeth Stonesifer, MD
Penn State Milton S. Hershey Medical Center